Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases
Linyan Duan, Xingfan Li, Rong Ji, et al.
Polymers (2023) Vol. 15, Iss. 9, pp. 2196-2196
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier
Su Hyun Lim, Gi Taek Yee, Dongwoo Khang
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2529-2552
Open Access | Times Cited: 10
Blood–Brain Barrier-Targeting Nanoparticles: Biomaterial Properties and Biomedical Applications in Translational Neuroscience
Evridiki Asimakidou, Justin Kok Soon Tan, Jialiu Zeng, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 612-612
Open Access | Times Cited: 10
The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 386-386
Open Access
Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
Fatih Çiftçi, Ali Can Özarslan, İmran Cagri Kantarci, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 121-121
Open Access
Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implications
Pharaoh Fellow Mwale, Cheng-Ta Hsieh, Ting‐Lin Yen, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Nanoparticle Interactions with the Blood Brain Barrier: Insights from Drosophila and Implications for Human Astrocyte Targeted Therapies
Akshata Choudhari Padti, Santosh Mallikarjun Bhavi, Bothe Thokchom, et al.
Neurochemical Research (2025) Vol. 50, Iss. 1
Closed Access
Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives
Virendra Kumar Yadav, Seshathiri Dhanasekaran, Nisha Choudhary, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Influence of Iron(III) Oxide Nanorods on the Mechanical and Thermal Properties of Pan Nanofiber Mats
Jaymin Vrajlal Sanchaniya, Karunamoorthy Rengasamy Kannathasan, H. K. Muraleedharan, et al.
Latvian Journal of Physics and Technical Sciences (2025) Vol. 62, Iss. 1, pp. 78-86
Open Access
Nanotechnology in Parkinson’s Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes
Irfan Ali, Mohammad Adil, Mohammad Imran, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Tailored Intranasal Albumin Caged Selegiline-α Synuclein siRNA Liposome with Improved Efficiency in Parkinson’s Model
Ahmed A. Katamesh, Hend Mohamed Abdel‐Bar, Mohammed Khaled Bin Break, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 243-243
Open Access
Challenges and opportunities for improving the druggability of natural product: Why need drug delivery system?
Peng Tang, Tianze Shen, Hairong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114955-114955
Open Access | Times Cited: 15
Glucose-modified BSA/procyanidin C1 NPs penetrate the blood-brain barrier and alleviate neuroinflammation in Alzheimer's disease models
Linyan Duan, Zhizhong Hao, Rong Ji, et al.
International Journal of Biological Macromolecules (2024) Vol. 268, pp. 131739-131739
Closed Access | Times Cited: 4
Hybrid Organic–Inorganic Biomaterials as Drug Delivery Systems: A Molecular Dynamics Study of Quercetin Adsorption on Amorphous Silica Surfaces
Giuseppina Raffaini, Pasqualina Pirozzi, Michelina Catauro, et al.
Coatings (2024) Vol. 14, Iss. 2, pp. 234-234
Open Access | Times Cited: 3
Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases
Andreas Tapia-Arellano, Pablo Cabrera, Elizabeth Cortés-Adasme, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Recent developments in selective therapeutic targeting of functionalized nanomaterials to neurovascular units in overcoming the gaps in neurovascular therapy
Sakshi Goswami, Н. К. Исаев, Vladimir V. Salmin, et al.
Brain Disorders (2024) Vol. 15, pp. 100162-100162
Open Access | Times Cited: 3
Designing and Formulation of Nanocarriers for “Alzheimer’s and Parkinson’s” Early Detection and Therapy
Jakleen Abujamai, Rukhsana Satar, Shakeel Ahmed Ansari
CNS & Neurological Disorders - Drug Targets (2024) Vol. 23, Iss. 10, pp. 1251-1262
Closed Access | Times Cited: 3
Advances in Gene and Cellular Therapeutic Approaches for Huntington’s Disease
Xuejiao Piao, Dan Li, Hui Liu, et al.
Protein & Cell (2024)
Open Access | Times Cited: 2
Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons
Minhye Kim, Myeongyeon Shin, Yaping Zhao, et al.
Small Science (2024)
Open Access | Times Cited: 2
Harnessing the power of natural alkaloids: the emergent role in epilepsy therapy
Siyu Li, Xinyu Lin, Lijuan Duan
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
Tuan Hiep Tran, Thi Thu Phuong Tran
International Immunopharmacology (2024) Vol. 142, pp. 113085-113085
Closed Access | Times Cited: 1
Nanotechnological advancement for the treatment of neurodegenerative disorders
Garima Rai, Surbhi Sharma, Aditi Singh, et al.
Journal of Dispersion Science and Technology (2024), pp. 1-19
Closed Access | Times Cited: 1
Recent Advances in Nanomaterials for Neural Applications: Opportunities and Challenges
S. Natarajan, R. Shalini, S. Ramya, et al.
Nanomedicine (2023) Vol. 18, Iss. 26, pp. 1979-1994
Closed Access | Times Cited: 4
Nanopharmacology as a new approach to treat neuroinflammatory disorders
Sebastián García Menéndez, Walter Manucha
Translational Neuroscience (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Role of lysosome in healing neurological disorders by nano-bioengineering
Aiswarya Raj, Urmi Bandyopadhyay
Frontiers in Neuroscience (2024) Vol. 17
Open Access
Revolutionizing Medicine: Advances in Polymeric Drug Delivery Systems
Rahul Bijwar, Harshal Tare
International Journal of Drug Delivery Technology (2024) Vol. 14, Iss. 01, pp. 572-580
Open Access
Page 1 - Next Page

Scroll to top